Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG

38 Management Report Konzernlagebericht
EBIT development
biolitec’s EBIT
K Euro
2009/2010 (45)
2008/2009 2,581
2007/2008 2,581
2006/2007 6,902
2005/2006 2,268
per 30.06.2010
Financial status
Cash flow from operating activities amounted to EUR 7.8 million (previous year: EUR 1.5 million). The
cash effective components of the group’s net income and the continued decrease in circulating assets
made this increase possible.
The cash flow balance from investment activities amounted to EUR -4.6 million (previous year: EUR -3.7
million). Investments were primarily made by the subsidiaries Ceramoptec GmbH and biolitec Inc. The
Cash flow from financing activities of EUR -1.5 million is slightly above last year’s cash flow (EUR -1.7 million).
The funds flow is especially connected with the scheduled amortization of loan and leasing liabilities.
During the financial year 2009/2010 the liquid funds increased from EUR 6.2 million at the beginning of
the financial year by EUR 1.7 million up to EUR 7.9 million at the end of the financial year.
Development of liquid funds
biolitec’s liquid assets
K Euro
2009/2010 7,897
2008/2009 6,223
2007/2008 10,243
2006/2007 4,262
2005/2006 3,248
per 30.06.2010
Net asset position
At the end of the year the consolidated balance-sheet total amounted to EUR 62.0 million compared to
EUR 61.8 million at last year’s due date. The stock-in-trade could be lowered to EUR 2.6 million compared
to last year. For 2010/2011 a further reduction in stock is planned.